Back to Woodline Partners LP Woodline Partners LP

REGNREGN
Showing 8 of 26 quarters

Position history for Woodline Partners LPWoodline Partners LP's holdings in REGENERON PHARMACEUTICALS

Woodline Partners LP holds 72,595 shares of REGN (REGENERON PHARMACEUTICALS), worth $45.3M as of 2026-Q2. The position was increased (+7.2% shares). REGN represents 0.1% of Woodline Partners LP's portfolio.

Current Value

$45.3M

Current Shares

72,595

Total Value Change

-$59.2M

Total Shares Change

-26,822

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
72,595
+7.2%
$45.3M0.1%$623.54
37
2026-Q1
Increased
67,751
+4.3%
$52.3M0.2%$766.66
37
2025-Q4
Increased
64,968
+6.6%
$50.1M0.2%$773.94
37
2025-Q3
Increased
60,964
+3.7%
$34.3M0.2%$560.05
36
2025-Q2
Decreased
58,778
-44.7%
$30.9M0.2%$519.56
0
2025-Q1
Increased
106,217
+2.8%
$67.4M0.4%$634.66
36
2024-Q4
Increased
103,279
+3.9%
$73.6M0.5%$698.71
37
2024-Q3
Decreased
99,417
-45.3%
$104.5M0.9%$1,036.94
0

Other major holders of REGN: BNP PARIBAS FINANCIAL MARKETS, VANGUARD GROUP INC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used